Nada Abla
Impact in
- Pharmaceutical Science top 5%
- Advancements in Transdermal Drug Delivery
- Advanced Drug Delivery Systems
- Parasitology top 10%
- Parasites and Host Interactions
Papers in
-
- Computational Drug Discovery Methods 8
-
- Malaria Research and Control 7
- Co-authors
- Richard H. Guy (4 shared papers)Aarti Naik (4 shared papers)Yogeshvar N. Kalia (4 shared papers)Susan J. Johns (1 shared paper)Leslie W. Chinn (1 shared paper)Travis R. Taylor (1 shared paper)Tsutomu Nakamura (1 shared paper)Howard Burt (4 shared papers)
- Journals
- Pharmaceutical Research (3 papers)ACS Medicinal Chemistry Letters (2 papers)Clinical and Translational Science (2 papers)CPT Pharmacometrics & Systems Pharmacology (2 papers)Journal of Controlled Release (2 papers)
- Partner nations
- SwitzerlandUnited KingdomUnited States
In The Last Decade
Nada Abla
21 papers receiving 395 citations
Peers
Comparison fields: 5 of 78
- Pharmaceutical Science 108
- Parasitology 48
- Dermatology 35
- Small Animals 24
- Pharmacology 28
Countries citing papers authored by Nada Abla
This map shows the geographic impact of Nada Abla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nada Abla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nada Abla more than expected).
Fields of papers citing papers by Nada Abla
This network shows the impact of papers produced by Nada Abla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nada Abla. The network helps show where Nada Abla may publish in the future.
Co-authors
The 25 scholars most cited alongside Nada Abla, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 88 | |
| 2 | 2005 | 45 | |
| 3 | 2013 | 37 | |
| 4 | 2005 | 34 | |
| 5 | 2017 | 30 | |
| 6 | 2014 | 24 | |
| 7 | 2006 | 21 | |
| 8 | 2018 | 19 | |
| 9 | 2005 | 17 | |
| 10 | 2018 | 15 | |
| 11 | 2023 | 13 | |
| 12 | 2009 | 13 | |
| 13 | 2022 | 12 | |
| 14 | 2017 | 11 | |
| 15 | 2020 | 6 | |
| 16 | 2022 | 4 | |
| 17 | 2021 | 4 | |
| 18 | 2024 | 2 | |
| 19 | 2024 | 2 | |
| 20 | 2024 | 2 |
About Nada Abla
Nada Abla is a scholar working on Computational Theory and Mathematics, Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health, Molecular Biology and Pharmaceutical Science, having authored 23 papers that have together received 401 indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (8 papers), Malaria Research and Control (7 papers), Pharmacogenetics and Drug Metabolism (5 papers), Advancements in Transdermal Drug Delivery (5 papers), Pharmacological Effects and Toxicity Studies (4 papers), Lipid Membrane Structure and Behavior (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). The work is most often cited by research in Pharmaceutical Science (108 citations), Parasitology (48 citations), Dermatology (35 citations), Small Animals (24 citations) and Pharmacology (28 citations). Nada Abla has collaborated with scholars based in Switzerland, United Kingdom and United States. Frequent co-authors include Richard H. Guy, Aarti Naik, Yogeshvar N. Kalia, Susan J. Johns, Leslie W. Chinn, Travis R. Taylor, Tsutomu Nakamura, Howard Burt, Deanna L. Kroetz and Jennifer Keiser. Their work appears in journals such as Pharmaceutical Research, ACS Medicinal Chemistry Letters, Clinical and Translational Science, CPT Pharmacometrics & Systems Pharmacology and Journal of Controlled Release.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.